MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-181

  1. 2,476 Posts.
    lightbulb Created with Sketch. 274
    and will these results demonstrate the MOA?

    because I'm pretty sure that effectiveness has already been demonstrated by concerns around MOA and consistency of production are the real bugbears here.

    but you all keep bleating on about results results results.

    newsflash - the FDA were less concerned about the results of msb gvhd treatment and more concerned with the science behind WHY it was effective.

    the cheerleaders here don't want you to dwell too much on this point because clearly it's still a concern for chf and clbp.

    the smart money has already sold out substantially IMO.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.